Endothelial dysfunction in chronic kidney disease: a clinical perspective.

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Vascular Biology

Background:

• Chronic kidney disease (CKD) is a progressive condition linked to increased cardiovascular (CV) morbidity and mortality.
• The endothelium, crucial for vascular tone and integrity, produces nitric oxide (NO) and other relaxing factors.
• Endothelial dysfunction, marked by reduced NO and increased vasoconstrictors, is a key factor in CKD progression.

Purpose of the Study:

• To review clinical evidence of CKD-associated endothelial dysfunction in micro- and macrovasculature.
• To discuss the underlying physiological mechanisms contributing to endothelial dysfunction in CKD.
• To summarize current and emerging pharmacotherapies and lifestyle interventions for CKD-related endothelial dysfunction.

Main Methods:

• Review of clinical studies examining endothelium-dependent vasodilation in CKD patients.
• Analysis of physiological mechanisms implicated in endothelial dysfunction.
• Synthesis of data on pharmacotherapies and exercise interventions.

Main Results:

• Endothelial dysfunction is a prevalent and independent predictor of CV events in CKD.
• Reduced NO bioavailability and altered vascular tone are characteristic of CKD.
• Various factors including uremia, inflammation, and oxidative stress contribute to endothelial dysfunction.

Conclusions:

• Endothelial dysfunction significantly contributes to the high CV risk in CKD patients.
• Understanding these mechanisms is vital for developing effective treatments.
• Pharmacological and lifestyle interventions show promise in mitigating CKD-related vascular complications.